CH532659A - Procédé de culture de virus et de préparation de vaccins à partir de cellules IB-RS-2 - Google Patents

Procédé de culture de virus et de préparation de vaccins à partir de cellules IB-RS-2

Info

Publication number
CH532659A
CH532659A CH685071A CH685071A CH532659A CH 532659 A CH532659 A CH 532659A CH 685071 A CH685071 A CH 685071A CH 685071 A CH685071 A CH 685071A CH 532659 A CH532659 A CH 532659A
Authority
CH
Switzerland
Prior art keywords
cells
preparing vaccines
culturing viruses
viruses
culturing
Prior art date
Application number
CH685071A
Other languages
English (en)
French (fr)
Inventor
Brunet Paul
Original Assignee
Bellon Labor Sa Roger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellon Labor Sa Roger filed Critical Bellon Labor Sa Roger
Publication of CH532659A publication Critical patent/CH532659A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18161—Methods of inactivation or attenuation
    • C12N2760/18164—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32161—Methods of inactivation or attenuation
    • C12N2770/32164—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH685071A 1970-05-11 1971-05-10 Procédé de culture de virus et de préparation de vaccins à partir de cellules IB-RS-2 CH532659A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR707017053A FR2088038B1 (pl) 1970-05-11 1970-05-11

Publications (1)

Publication Number Publication Date
CH532659A true CH532659A (fr) 1973-01-15

Family

ID=9055329

Family Applications (1)

Application Number Title Priority Date Filing Date
CH685071A CH532659A (fr) 1970-05-11 1971-05-10 Procédé de culture de virus et de préparation de vaccins à partir de cellules IB-RS-2

Country Status (12)

Country Link
BE (1) BE766442A (pl)
CH (1) CH532659A (pl)
CS (1) CS178080B2 (pl)
DE (1) DE2121237C3 (pl)
DK (1) DK129468B (pl)
ES (1) ES390873A1 (pl)
FR (1) FR2088038B1 (pl)
GB (1) GB1338043A (pl)
HU (1) HU165705B (pl)
NL (1) NL7106379A (pl)
PL (1) PL88908B1 (pl)
RO (1) RO62179A (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8801601A (nl) * 1988-06-23 1990-01-16 Centraal Diergeneeskundig Inst Een "swine-kidney" celcultuur, geschikt voor het kweken van virussen, een daaraan geadapteerde "chinese" stam van het varkenspestvirus, alsmede de hiervan afgeleide vaccins.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1299514A (fr) * 1960-11-25 1962-07-27 Bayer Ag Procédé de reproduction du virus de la fièvre aphteuse
DE1174016B (de) * 1962-05-18 1964-07-16 Behringwerke Ag Verfahren zur Herstellung einer Lebend-Vaccine gegen Maul- und Klauenseuche

Also Published As

Publication number Publication date
FR2088038A1 (pl) 1972-01-07
BE766442A (fr) 1971-09-16
HU165705B (pl) 1974-10-28
ES390873A1 (es) 1975-03-16
DE2121237C3 (de) 1980-03-06
DE2121237A1 (de) 1971-12-02
RO62179A (pl) 1977-05-15
NL7106379A (pl) 1971-11-15
GB1338043A (en) 1973-11-21
CS178080B2 (pl) 1977-08-31
FR2088038B1 (pl) 1973-08-10
DE2121237B2 (de) 1979-07-05
PL88908B1 (pl) 1976-10-30
DK129468B (da) 1974-10-14
DK129468C (pl) 1975-03-03

Similar Documents

Publication Publication Date Title
OA04704A (fr) Procédé de préparation de nouveaux vaccins.
DK145613C (da) Apparat til dyrkning af vaevskulturceller
BE826568A (fr) Procede de preparation de vaccins vivants contre la varicelle
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
CS191868B2 (en) Method of preparing live virus vaccine
BE808708A (fr) Vaccins vivants contre la rhinotracheite infectieuse bovine et leur preparation
CH532659A (fr) Procédé de culture de virus et de préparation de vaccins à partir de cellules IB-RS-2
BE824372A (fr) Vaccins antigrippaux et procede de leur preparation
ES432385A1 (es) Un metodo de obtener una cepa de virus de la gripe.
BE777369A (fr) Vaccin contre la gourme equine et procede de sa preparation
NO142024C (no) Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus
ES8200398A1 (es) Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.
GB1436323A (en) Cell and virus culture systems
BE766093A (fr) Procede de preparation de vaccins actifs viraux
FR1502631A (fr) Procédé de culture d'un virus morbilleux
BE795293A (fr) Procede de culture en masse de virus de la fievre aphteuse
BE832200A (fr) Esters sulfosucciniques et procede de leur preparation
BE776079A (fr) Vaccin contre le virus de la rhinotracheite bovine infectieuse,son procede de preparation et son utilisation
BE842814A (fr) Compositions antigeniques, leur procede de preparation et leur application comme vaccins
AU457758B2 (en) Infectious bovine rhinotracheitis virus vaccine and method of preparing and using thesame
AR212170A1 (es) Medio de cultivo de celulas para la produccion de virus utilizables en la elaboracion de vacunas y un procedimiento para la preparacion de una vacuna mediante dicho medio de cultivo
BE752918A (fr) Enzymes obtenues par culture d'une espece cephalosporium, et methodes pour leur preparation, isolement et purification
AU3626071A (en) Infectious bovine rhinotracheitis virus vaccine and method of preparing and using thesame
FR1482817A (fr) Nouveau procédé de lyophilisation de cultures de micro-organismes
BE776751A (fr) Procede de preparation des acrylates et des

Legal Events

Date Code Title Description
PL Patent ceased